Bundibugyo Ebola Outbreak in the DRC: Why WHO Says the Response Is Improving but the Risk Is Not Over
The Bundibugyo virus outbreak in the Democratic Republic of the Congo has entered a complicated phase: health authorities are seeing encouraging signs in some locations, while the overall outbreak continues to produce new cases, deaths and geographic expansion. The World Health Organization’s latest updates describe an emergency that is no longer confined to one cluster, but they also point to a response that is becoming more organised.
In remarks on 16 September, WHO Director-General Tedros Adhanom Ghebreyesus said transmission was going down in the hardest-hit parts of Ituri and that more than 1,700 people had recovered. He also stressed that the epidemic continued to grow and kill. WHO’s alert-and-response table, using data through 16 September, listed 7,475 confirmed cases and 3,605 confirmed deaths in the DRC, with additional confirmed cases in Uganda and one imported case in France. The figures can be revised as laboratories reconcile records and as delayed reports arrive.
What makes this outbreak difficult
Bundibugyo virus is one of the viruses that causes Ebola disease, but it is not the same species as the Zaire ebolavirus targeted by the licensed Ervebo vaccine. WHO has therefore advised that Ervebo should be used against Bundibugyo virus only inside a research protocol because its effectiveness against this species in humans is not established. That distinction is important: a headline saying ‘an Ebola vaccine exists’ does not mean there is a proven, broadly deployable vaccine for every Ebola species.
The response is also taking place in conflict-affected areas, mining communities and settlements where healthcare access is limited. WHO has reported that overcrowding, poor water and sanitation services, displacement and insecurity can delay the recognition of illness and make contact tracing harder. Informal border crossings create another challenge. Even when official screening is operating at airports, ports and land crossings, people may continue to move through routes that health teams cannot easily monitor.
Where transmission is concentrated
Ituri remains the epicentre, with thousands of confirmed cases since the outbreak began. North Kivu has also become a major concern, with the WHO reporting a rise in recent weekly cases. South Kivu has not reported new cases since May, a development that offers a useful example of what sustained surveillance and response can achieve, but it does not remove the risk of reintroduction.
Uganda’s small outbreak was linked to imported cases from the DRC, and WHO says the last confirmed Ugandan patient was discharged in July. France reported one imported case that was discharged in July. These recoveries are reassuring, but they also show why cross-border cooperation matters: people, families and healthcare workers do not stop at the edge of a map.
What health workers are doing
Authorities are combining laboratory confirmation, case isolation, contact tracing, infection prevention and control, community engagement and supportive care. WHO says a treatment trial, known as PARTNERS, has enrolled more than 300 confirmed patients in clinical management facilities in Ituri. Vaccine trials are also being prepared. Such research is not an instant solution, but it may produce the evidence needed to expand treatment and prevention options in future outbreaks.
Community trust is as important as laboratory capacity. Families may delay seeking care if they fear isolation, stigma or loss of income. Response teams therefore need to explain what symptoms to watch for, how contacts are followed and why protective measures are used. Transparent communication can reduce rumours and improve the chance that patients arrive early enough to receive supportive treatment.
What the international risk means
WHO’s reporting does not say that a global pandemic is under way. It does say that sustained transmission and movement across borders create a risk that must be actively managed. For people outside the affected region, the practical response is to rely on official travel and health advice rather than online speculation. For governments and aid organisations, the lesson is more demanding: surveillance, protective equipment, trained staff and safe transport must be maintained even when case numbers begin to fall in one province.
The outbreak is therefore best described as serious but not hopeless. Lower transmission in parts of Ituri, recoveries and Uganda’s containment are real achievements. The continuing case burden, high case-fatality ratio and expansion into additional health zones are equally real warnings. WHO’s data show why public-health progress should be measured in weeks of surveillance and confirmed epidemiology, not a single optimistic headline.
Sources
- WHO Disease Outbreak News: Bundibugyo virus disease in the DRC
- WHO alert-and-response table, updated 16 September 2026
- WHO Director-General’s 16 September briefing
